Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome

Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome

10 30 2023Подробнее

10 30 2023

Jurjen Versluis: Transplant for high-risk MDS | #18 | Trainee PearlsПодробнее

Jurjen Versluis: Transplant for high-risk MDS | #18 | Trainee Pearls

07 - Treosulfan compared with RIC busulfan improves AlloHSCT outcomes of older AML and MDSПодробнее

07 - Treosulfan compared with RIC busulfan improves AlloHSCT outcomes of older AML and MDS

BMT CTN 1102: pre-transplantation QoL measures improve prognostication in HR-MDSПодробнее

BMT CTN 1102: pre-transplantation QoL measures improve prognostication in HR-MDS

Optimising transplant outcome in adults allografted for AMLПодробнее

Optimising transplant outcome in adults allografted for AML

Outcomes for High-Risk MDS Patients Undergoing Transplant vs Standard Non-Transplant TherapiesПодробнее

Outcomes for High-Risk MDS Patients Undergoing Transplant vs Standard Non-Transplant Therapies

Transplant Outcomes in Older Adults with MDS and AML 2021Подробнее

Transplant Outcomes in Older Adults with MDS and AML 2021

How to improve transplant outcomes in MDS?Подробнее

How to improve transplant outcomes in MDS?

FLAMSU-Bu conditioning doesn't improve outcome in AML/MDS irrespective of pre-transplant MRD statusПодробнее

FLAMSU-Bu conditioning doesn't improve outcome in AML/MDS irrespective of pre-transplant MRD status

My approach to MDS managementПодробнее

My approach to MDS management

MDS: Before and After Stem Cell TransplantationПодробнее

MDS: Before and After Stem Cell Transplantation

Stem Cell Transplant Approaches to MDSПодробнее

Stem Cell Transplant Approaches to MDS

WSCS 2015: Stem Cell Transplant HDПодробнее

WSCS 2015: Stem Cell Transplant HD

Популярное